Literature DB >> 8552074

Transcriptional down regulation of the nov proto-oncogene in fibroblasts transformed by p60v-src.

G Scholz1, C Martinerie, B Perbal, H Hanafusa.   

Abstract

We have sought to identify genes whose expression is altered as a consequence of transformation by p60v-src. Using the mRNA differential display method, we have identified the nov proto-oncogene as one gene that is down regulated in chicken embryo fibroblasts (CEFs) transformed by p60v-src. nov transcripts were also found to be present at only very low levels in proliferating CEFs in comparison with quiescent CEFs. Serum stimulation of quiescent CEFs also resulted in a decline in the steady-state level of nov transcripts. Taken together, these findings suggest that the nov gene is expressed only in quiescent fibroblasts and that its down regulation may contribute to cellular transformation by the v-src oncogene. Down regulation of the nov gene appears to occur at both the transcriptional and posttranscriptional levels. Results obtained from experiments with a protein kinase inhibitor suggest that protein kinase C may be a key downstream effector in mediating the down regulation of nov transcripts in response to activation of p60src or serum stimulation. In addition, we found that transcription of an unknown gene is required for the decline in the steady-state level of nov transcripts in response to serum stimulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8552074      PMCID: PMC231025          DOI: 10.1128/MCB.16.2.481

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  The membrane-binding domain and myristylation of p60v-src are not essential for stimulation of cell proliferation.

Authors:  G Calothy; D Laugier; F R Cross; R Jove; T Hanafusa; H Hanafusa
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

Review 2.  Protein-tyrosine kinases.

Authors:  T Hunter; J A Cooper
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  Transcriptional downregulation of the retina-specific QR1 gene by pp60v-src and identification of a novel v-src-responsive unit.

Authors:  A Pierani; C Pouponnot; G Calothy
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

4.  Molecular cloning and characterization of a cDNA showing negative regulation in v-src-transformed 3Y1 rat fibroblasts.

Authors:  T Ozaki; S Sakiyama
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

5.  A turnover pathway for both stable and unstable mRNAs in yeast: evidence for a requirement for deadenylation.

Authors:  C J Decker; R Parker
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

6.  Physical mapping of human loci homologous to the chicken nov proto-oncogene.

Authors:  C Martinerie; E Viegas-Pequignot; I Guenard; B Dutrillaux; V C Nguyen; A Bernheim; B Perbal
Journal:  Oncogene       Date:  1992-12       Impact factor: 9.867

7.  Activation of YRP kinase by v-Src and protein kinase C-mediated signal transduction pathways.

Authors:  G Scholz; M P Felder; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 8.  Contribution of MAV-1-induced nephroblastoma to the study of genes involved in human Wilms' tumor development.

Authors:  B Perbal
Journal:  Crit Rev Oncog       Date:  1994

9.  c phosphorylation and activation of the IGF-I receptor in src-transformed cells.

Authors:  J E Peterson; T Jelinek; M Kaleko; K Siddle; M J Weber
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

10.  Structural analysis of the human nov proto-oncogene and expression in Wilms tumor.

Authors:  C Martinerie; V Huff; I Joubert; M Badzioch; G Saunders; L Strong; B Perbal
Journal:  Oncogene       Date:  1994-09       Impact factor: 9.867

View more
  25 in total

Review 1.  NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.

Authors:  B Perbal
Journal:  Mol Pathol       Date:  2001-04

2.  The noncoding and surface envelope coding sequences of myeloblastosis-associated virus are respectively responsible for nephroblastoma development and renal hyperplasia.

Authors:  V Joliot; C Khelifi; M Wyers; G Dambrine; F Lasserre; P Lemercier; B Perbal
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

3.  Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation.

Authors:  R Zhang; L Averboukh; W Zhu; H Zhang; H Jo; P J Dempsey; R J Coffey; A B Pardee; P Liang
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

4.  Suppression of v-src transformation by the drs gene.

Authors:  H Inoue; J Pan; A Hakura
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  CCN proteins: A centralized communication network.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2013-02-19       Impact factor: 5.782

6.  Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues.

Authors:  M Maillard; B Cadot; R Y Ball; K Sethia; D R Edwards; B Perbal; R Tatoud
Journal:  Mol Pathol       Date:  2001-08

7.  The expression of ccn3 (nov) RNA and protein in the rat central nervous system is developmentally regulated.

Authors:  B Y Su; W Q Cai; C G Zhang; V Martinez; A Lombet; B Perbal
Journal:  Mol Pathol       Date:  2001-06

8.  Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo.

Authors:  A M Babic; C C Chen; L F Lau
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

9.  novH: differential expression in developing kidney and Wilm's tumors.

Authors:  G Chevalier; H Yeger; C Martinerie; M Laurent; J Alami; P N Schofield; B Perbal
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

10.  Cellular processes of v-Src transformation revealed by gene profiling of primary cells--implications for human cancer.

Authors:  Bart M Maślikowski; Benjamin D Néel; Ying Wu; Lizhen Wang; Natalie A Rodrigues; Germain Gillet; Pierre-André Bédard
Journal:  BMC Cancer       Date:  2010-02-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.